Literature DB >> 19406203

Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex.

Prerna Sethi1, Walter J Lukiw.   

Abstract

Micro-RNA (miRNA) mediated regulation of messenger RNA (mRNA) complexity in the central nervous system (CNS) is emerging as a critical factor in the control of CNS-specific gene expression during development, plasticity, aging and disease. In these studies, miRNA array and Northern blot based tracking of specific miRNA abundances and decay kinetics in human neural (HN) cells in primary culture and in short post-mortem interval (PMI, approximately 1h) human brain tissues showed a limited stability and relatively short half-life ( approximately 1-3.5h) for specific brain-enriched miRNAs. In short PMI Alzheimer's disease (AD)-affected temporal lobe neocortex, miRNA-9, miRNA-125b and miRNA-146a were found to be significantly up-regulated, an effect that was not seen in several related neurological disorders. The results suggest (a) that unless specifically stabilized, certain brain-enriched miRNAs represent a rapidly executed signaling system employing highly transient effectors of CNS gene expression, and (b) that in AD temporal lobe neocortex specific brain miRNAs are significantly up-regulated in abundance and strongly correlate with the presence of AD-type neuropatholgical change.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406203     DOI: 10.1016/j.neulet.2009.04.052

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  199 in total

1.  Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA.

Authors:  Walter J Lukiw; Peter N Alexandrov; Yuhai Zhao; James M Hill; Surjyadipta Bhattacharjee
Journal:  Neuroreport       Date:  2012-07-11       Impact factor: 1.837

2.  NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells.

Authors:  Walter J Lukiw
Journal:  Exp Neurol       Date:  2011-11-23       Impact factor: 5.330

3.  Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome.

Authors:  W J Lukiw; P Dua; A I Pogue; C Eicken; J M Hill
Journal:  J Toxicol Environ Health A       Date:  2011

4.  Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD).

Authors:  Walter J Lukiw; Bhattacharjee Surjyadipta; Prerna Dua; Peter N Alexandrov
Journal:  Int J Biochem Mol Biol       Date:  2012-03-20

Review 5.  Regulation of small RNA stability: methylation and beyond.

Authors:  Lijuan Ji; Xuemei Chen
Journal:  Cell Res       Date:  2012-03-13       Impact factor: 25.617

Review 6.  Functions of noncoding RNAs in neural development and neurological diseases.

Authors:  Shan Bian; Tao Sun
Journal:  Mol Neurobiol       Date:  2011-10-04       Impact factor: 5.590

Review 7.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

Review 8.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

Authors:  John R Finnerty; Wang-Xia Wang; Sébastien S Hébert; Bernard R Wilfred; Guogen Mao; Peter T Nelson
Journal:  J Mol Biol       Date:  2010-08-01       Impact factor: 5.469

Review 9.  Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases.

Authors:  Patrick Provost
Journal:  Aging (Albany NY)       Date:  2010-03-31       Impact factor: 5.682

Review 10.  MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.

Authors:  Patrick Provost
Journal:  Brain Res       Date:  2010-03-27       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.